1. Home
  2. SNGX vs ARTW Comparison

SNGX vs ARTW Comparison

Compare SNGX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • ARTW
  • Stock Information
  • Founded
  • SNGX 1987
  • ARTW 1956
  • Country
  • SNGX United States
  • ARTW United States
  • Employees
  • SNGX N/A
  • ARTW N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • SNGX Health Care
  • ARTW Industrials
  • Exchange
  • SNGX Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • SNGX 7.4M
  • ARTW 8.6M
  • IPO Year
  • SNGX 1987
  • ARTW N/A
  • Fundamental
  • Price
  • SNGX $2.32
  • ARTW $1.80
  • Analyst Decision
  • SNGX
  • ARTW
  • Analyst Count
  • SNGX 0
  • ARTW 0
  • Target Price
  • SNGX N/A
  • ARTW N/A
  • AVG Volume (30 Days)
  • SNGX 620.7K
  • ARTW 199.7K
  • Earning Date
  • SNGX 03-14-2025
  • ARTW 02-26-2025
  • Dividend Yield
  • SNGX N/A
  • ARTW N/A
  • EPS Growth
  • SNGX N/A
  • ARTW N/A
  • EPS
  • SNGX N/A
  • ARTW N/A
  • Revenue
  • SNGX $364,183.00
  • ARTW $25,181,639.00
  • Revenue This Year
  • SNGX N/A
  • ARTW N/A
  • Revenue Next Year
  • SNGX $76.64
  • ARTW N/A
  • P/E Ratio
  • SNGX N/A
  • ARTW N/A
  • Revenue Growth
  • SNGX N/A
  • ARTW N/A
  • 52 Week Low
  • SNGX $0.32
  • ARTW $1.33
  • 52 Week High
  • SNGX $14.83
  • ARTW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 36.12
  • ARTW 45.76
  • Support Level
  • SNGX $2.23
  • ARTW $1.60
  • Resistance Level
  • SNGX $2.39
  • ARTW $1.75
  • Average True Range (ATR)
  • SNGX 0.17
  • ARTW 0.10
  • MACD
  • SNGX 0.01
  • ARTW -0.01
  • Stochastic Oscillator
  • SNGX 22.12
  • ARTW 27.78

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: